WO2011095984A1 - Procédé de préparation d'ésoméprazole amorphe - Google Patents

Procédé de préparation d'ésoméprazole amorphe Download PDF

Info

Publication number
WO2011095984A1
WO2011095984A1 PCT/IN2011/000042 IN2011000042W WO2011095984A1 WO 2011095984 A1 WO2011095984 A1 WO 2011095984A1 IN 2011000042 W IN2011000042 W IN 2011000042W WO 2011095984 A1 WO2011095984 A1 WO 2011095984A1
Authority
WO
WIPO (PCT)
Prior art keywords
esomeprazole
amorphous
solvent
solution
acid
Prior art date
Application number
PCT/IN2011/000042
Other languages
English (en)
Inventor
Joseph Prabahar Koilpillai
Hemant Nimba Raundal
Nagan Nirmalan Kandasamy
Hiremath Veerabhadra Swamy
Milind Moreshwar Gharpure
Mubeen Ahmed Khan
Original Assignee
Glenmark Generics Limited
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Glenmark Generics Limited filed Critical Glenmark Generics Limited
Publication of WO2011095984A1 publication Critical patent/WO2011095984A1/fr

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D401/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/12Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)

Abstract

L'invention concerne un procédé de préparation d'ésoméprazole sous forme amorphe par séchage par pulvérisation.
PCT/IN2011/000042 2010-02-02 2011-01-20 Procédé de préparation d'ésoméprazole amorphe WO2011095984A1 (fr)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
IN243MU2010 2010-02-02
IN243/MUM/2010 2010-02-02

Publications (1)

Publication Number Publication Date
WO2011095984A1 true WO2011095984A1 (fr) 2011-08-11

Family

ID=44355037

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/IN2011/000042 WO2011095984A1 (fr) 2010-02-02 2011-01-20 Procédé de préparation d'ésoméprazole amorphe

Country Status (1)

Country Link
WO (1) WO2011095984A1 (fr)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR3062129A1 (fr) * 2017-01-23 2018-07-27 Minakem Procede d'obtention du sel de magnesium dihydrate de l'esomeprazole

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1728997A (zh) * 2002-10-22 2006-02-01 兰贝克赛实验室有限公司 (es)奥美拉唑的无定形盐
US20070043085A1 (en) * 2005-08-19 2007-02-22 Glenmark Pharmaceuticals Limited Process for the preparation of amorphous form of neutral esomeprazole

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1728997A (zh) * 2002-10-22 2006-02-01 兰贝克赛实验室有限公司 (es)奥美拉唑的无定形盐
US20070043085A1 (en) * 2005-08-19 2007-02-22 Glenmark Pharmaceuticals Limited Process for the preparation of amorphous form of neutral esomeprazole

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR3062129A1 (fr) * 2017-01-23 2018-07-27 Minakem Procede d'obtention du sel de magnesium dihydrate de l'esomeprazole

Similar Documents

Publication Publication Date Title
JP5543982B2 (ja) Copdの処置に有用な5−ピラゾリル−2−ピリドン誘導体のトシル酸塩
US7589100B2 (en) Non-hygroscopic and powdery amorphous pimecrolimus
US20110021567A1 (en) Preparation of lenalidomide
US20140057925A1 (en) Amorphous form of vilazodone hydrochloride and process for its preparation
US20040010151A1 (en) Lansoprazole polymorphs and processes for preparation thereof
WO2012066565A2 (fr) Maléate d'asénapine amorphe et forme cristalline et procédé pour leur préparation
WO2014118808A2 (fr) Dispersion solide de ticagrelor
WO2007092779A2 (fr) Co-cristaux d'aripiprazole
US9879011B2 (en) Amorphous form of linagliptin and process for preparation thereof
WO2010129636A2 (fr) Lénalidomide polymorphe
WO2009084023A2 (fr) Rameltéon amorphe et son procédé de préparation
JP2023062091A (ja) S1p1受容体アゴニストの付加塩およびその結晶形態、ならびに薬学的組成物
KR102572035B1 (ko) 무정형 형태의 빌란테롤 트리페나테이트 및 이의 제조방법
EP1963306A2 (fr) Esomeprazole arginine
WO2011095984A1 (fr) Procédé de préparation d'ésoméprazole amorphe
US20100267959A1 (en) Process for the preparation of esomeprazole magnesium dihydrate
CN115463133A (zh) 一种药物组合物、制剂及其制备方法和应用
WO2014115169A2 (fr) Dispersion solide de crizotinib
US20090306106A1 (en) Forms of crystalline lapatinib and processes for preparation thereof
US20080014263A1 (en) Amorphous eprosartan mesylate and process for the preparation thereof
US20090318460A1 (en) Amorphous varenicline tartrate and process for the preparation thereof
US20070197467A1 (en) Zafirlukast compositions

Legal Events

Date Code Title Description
121 Ep: the epo has been informed by wipo that ep was designated in this application

Ref document number: 11739498

Country of ref document: EP

Kind code of ref document: A1

NENP Non-entry into the national phase

Ref country code: DE

122 Ep: pct application non-entry in european phase

Ref document number: 11739498

Country of ref document: EP

Kind code of ref document: A1